Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
OKYO Pharma to Present at Ophthalmology Futures European Forum and iNovation Day at ESCRS 2026
GlobeNewswire, Inc.
LONDON and NEW YORK, Sept. 09, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain (NCP) and anterior segment...
ThredUp Expands Into Live Shopping with Whatnot
GlobeNewswire, Inc.
OAKLAND, Calif., Sept. 29, 2026 (GLOBE NEWSWIRE) -- ThredUp (Nasdaq: TDUP, LTSE: TDUP), one of the world’s largest online resale platforms, today announced plans to expand into live shopping on Whatnot, the largest live commerce platform in the...
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Wise Group plc of Class Action Lawsuit and Upcoming Deadlines – WSE
GlobeNewswire, Inc.
NEW YORK, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Wise Group plc (“Wise” or the “Company”) (NASDAQ: WSE). Such investors are advised to contact Danielle Peyton at...
Pomerantz Law Firm Announces the Filing of a Class Action Against Microvast Holdings, Inc.and Certain Officers – MVST
GlobeNewswire, Inc.
NEW YORK, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Microvast Holdings, Inc. (“Microvast” or the “Company”) (NASDAQ: MVST) and certain officers.
Sold-Out DM Summit 2026 Equips 440 Orthodontic Professionals to Transform Their Practices with Remote Monitoring
EIN Presswire
Thirty-four speakers, 440 attendees, 14 continuing education credits, and hands-on doctor and team sessions helped practices put new workflows into action.
South Korea Investment Migration Draws Attention as European Golden Visas Tighten
EIN Presswire
As European golden visas tighten in 2026, global investors evaluate South Korea's fast-track investment residency as a strategic Asian alternative.
Aduro Clean Technologies to Present Hydrochemolytic™ Technology for Polyolefin Recycling at Chemical Recycling Europe Annual Conference 2026
GlobeNewswire, Inc.
LONDON, Ontario, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. (“Aduro” or the “Company”) (Nasdaq: ADUR) (TSX: ACT) (FSE: 9D5), a clean technology company using the power of chemistry to transform lower-value feedstocks, like...
DBV Technologies Announces Submission of Biologics License Application to U.S. FDA for the VIASKIN® Peanut Patch in Children Aged 4-7 Years
GlobeNewswire, Inc.
Châtillon, France, September 29, 2026 DBV Technologies Announces Submission of Biologics License Application to U.S. FDA for the VIASKIN® Peanut Patch in Children Aged 4-7 Years The BLA is supported by the results from the successful Phase 3...
My Green Lab Expands ACT Ecolabel Channel Partner Network Ahead of New EU Environmental Claims Rules
GlobeNewswire, Inc.
SAN DIEGO, Sept. 08, 2026 (GLOBE NEWSWIRE) -- My Green Lab® today announced that more than 15 laboratory product distributors, procurement platforms, and laboratory analytics platforms have joined its ACT® Ecolabel Channel Partner network,...
Leading European Real Assets Manager Stoneshield Capital to Join Forces with Franklin Templeton and Clarion Partners
GlobeNewswire, Inc.
NEW YORK, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Franklin Templeton, Inc. (“Franklin Templeton”) [NYSE: BEN], through its leading real estate subsidiary Clarion Partners, LLC, (“Clarion”), is pleased to announce that it has entered into a definitive...
T3 Defense Targets Accelerating European Demand for Air Defense Ground-System Components
GlobeNewswire, Inc.
NEW YORK and NETANYA, Israel, Sept. 08, 2026 (GLOBE NEWSWIRE) -- T3 Defense Inc. (Nasdaq: DFNS) (“T3 Defense” or the “Company”), a defense company that acquires and operates mission-critical defense businesses involved in national security...
The Elmet Group Co. Signs Agreement to Acquire ams OSRAM Schwabmünchen Metal Production Operations, Establishing European Manufacturing Footprint for Tungsten and Molybdenum Components
GlobeNewswire, Inc.
PORTLAND, Maine, Sept. 08, 2026 (GLOBE NEWSWIRE) -- The Elmet Group Co. (“Elmet,” the “Company,” “we,” or “our”) (NASDAQ: ELMT), a U.S.-based provider of precision-engineered components and advanced high-energy systems, today announced that it has...
Beam Therapeutics Presents Updated Clinical Data from the Phase 1/2 Trial of BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) at the European Respiratory Society (ERS) Congress 2026
GlobeNewswire, Inc.
BEAM-302 Continues to Demonstrate Potential as One-time Treatment for Both Lung and Liver Manifestations of AATD, with AAT Protein Production Under Normal Physiological Control With Up to 18 Months Follow-Up, Data Show Long-Term Durability of In...
Rafael Holdings Announces Topline Results from the Pivotal Phase 3 TransportNPC™ Study of Trappsol® Cyclo™ in Niemann-Pick Disease Type C (NPC)
GlobeNewswire, Inc.
Trappsol® Cyclo™ did not achieve statistical significance but demonstrated a directionally favorable treatment effect versus placebo on the primary endpoint of change in the 4-domain NPC Clinical Severity Scale (4DNPCSS) at Week 96 A prespecified...
Dyne Therapeutics Announces Additional One-Year Clinical Data from Phase 1/2 ACHIEVE Trial of Z-Basivarsen (DYNE-101) for Myotonic Dystrophy Type 1 (DM1)
GlobeNewswire, Inc.
- Data from a pooled dose group of participants initially enrolled in the multiple ascending dose (MAD) portion of ACHIEVE showed functional improvement versus baseline, versus placebo and versus a matched natural history cohort across multiple...
Jade Biosciences Announces Preclinical Data Characterizing JADE301, a Potentially Best-in-Class, Half-Life-Extended Anti-IFN-β Monoclonal Antibody in Development for Dermatomyositis, at EADV 2026
GlobeNewswire, Inc.
JADE301 is designed to build on a clinically validated IFN-β mechanism with a differentiated profile designed for infrequent subcutaneous dosing JADE301 demonstrated high-affinity, selective IFN-β binding and greater functional potency than a...
Connect Biopharma Announces Positive Preliminary Topline Data from its Global Phase 2 Study of Rademikibart as an Add-on Treatment for Acute Exacerbations in Adults with COPD and Type 2 Inflammation
GlobeNewswire, Inc.
– Rademikibart significantly reduced the rate of treatment failure compared to placebo through one month by 81% (p=0.0122) – – Rademikibart significantly reduced the rate of new moderate to severe COPD exacerbations through one month by 85%...
Pharmazz, Inc. Receives U.S. FDA IND Clearance to Initiate Phase 3 Clinical Trial of Sovateltide in Traumatic Brain Injury
GlobeNewswire, Inc.
Milestone Validates Proprietary Neural Repair Discovery Engine and Marks Major Expansion of First-in-Class Endothelin-B Receptor Agonist into a Critical Neurotrauma Indication with Significant Unmet Need Sovateltide is currently enrolling patients...
CVRx Announces Late-Breaking Data and New Clinical Evidence on Barostim at the HFSA Annual Scientific Meeting 2026
GlobeNewswire, Inc.
MINNEAPOLIS, Sept. 29, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX), a medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, announced...
Acquisition of Own Shares
GlobeNewswire, Inc.
Mechelen, Belgium; 29 September 2026, 22.01 CET; regulated information Within the framework of the repurchase program announced on June 9, 2026, Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT) ("Lakefront") announces that between September...
Sign up for:
The Europe Sun
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.